EDIT vs OKE
Editas Medicine Inc (EDIT) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
EDIT currently screens at market cap $375.2M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the EDIT and OKE stock pages for the full models.
Not investment advice.